Becton, Dickinson and Company (0R19.L)
USD 167.54
(-4.69%)
USD 167.54
(-4.69%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 1.48 Billion USD | -16.58% |
| 2022 | 1.77 Billion USD | -14.96% |
| 2021 | 2.09 Billion USD | 139.36% |
| 2020 | 874 Million USD | -29.12% |
| 2019 | 1.23 Billion USD | 296.46% |
| 2018 | 311 Million USD | -71.73% |
| 2017 | 1.1 Billion USD | 12.7% |
| 2016 | 976 Million USD | 40.43% |
| 2015 | 695 Million USD | -41.35% |
| 2014 | 1.18 Billion USD | 27.56% |
| 2013 | 929 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 281 Million USD | 160.19% |
| 2024 Q3 | 487 Million USD | -9.31% |
| 2024 Q2 | 537 Million USD | 91.1% |
| 2023 Q3 | 407 Million USD | -11.52% |
| 2023 Q2 | 460 Million USD | -9.63% |
| 2023 FY | 1.48 Billion USD | -16.58% |
| 2023 Q1 | 509 Million USD | 77.35% |
| 2023 Q4 | 108 Million USD | -73.46% |
| 2022 FY | 1.77 Billion USD | -14.96% |
| 2022 Q4 | 287 Million USD | -26.41% |
| 2022 Q3 | 390 Million USD | -14.1% |
| 2022 Q2 | 454 Million USD | -32.94% |
| 2022 Q1 | 677 Million USD | 155.47% |
| 2021 Q1 | 980 Million USD | 833.33% |
| 2021 Q3 | 525 Million USD | 2988.24% |
| 2021 FY | 2.09 Billion USD | 139.36% |
| 2021 Q4 | 265 Million USD | -49.52% |
| 2021 Q2 | 17 Million USD | -98.27% |
| 2020 Q3 | 277 Million USD | 91.03% |
| 2020 Q4 | 105 Million USD | -62.09% |
| 2020 FY | 874 Million USD | -29.12% |
| 2020 Q2 | 145 Million USD | -39.58% |
| 2020 Q1 | 240 Million USD | 93.55% |
| 2019 Q2 | -18 Million USD | -103.21% |
| 2019 FY | 1.23 Billion USD | 296.46% |
| 2019 Q4 | 124 Million USD | -69.98% |
| 2019 Q3 | 413 Million USD | 2394.44% |
| 2019 Q1 | 561 Million USD | 424.28% |
| 2018 FY | 311 Million USD | -71.73% |
| 2018 Q4 | -173 Million USD | -131.12% |
| 2018 Q3 | 556 Million USD | 1212.0% |
| 2018 Q2 | -50 Million USD | 71.26% |
| 2018 Q1 | -174 Million USD | -160.21% |
| 2017 Q4 | 289 Million USD | 276.22% |
| 2017 FY | 1.1 Billion USD | 12.7% |
| 2017 Q1 | 562 Million USD | 3022.22% |
| 2017 Q2 | 344 Million USD | -38.79% |
| 2017 Q3 | -164 Million USD | -147.67% |
| 2016 Q2 | 338 Million USD | 47.6% |
| 2016 Q3 | 390 Million USD | 15.38% |
| 2016 Q1 | 229 Million USD | 26.52% |
| 2016 Q4 | 18 Million USD | -95.38% |
| 2016 FY | 976 Million USD | 40.43% |
| 2015 Q2 | 216 Million USD | -8.47% |
| 2015 Q1 | 236 Million USD | -21.59% |
| 2015 FY | 695 Million USD | -41.35% |
| 2015 Q4 | 181 Million USD | 191.94% |
| 2015 Q3 | 62 Million USD | -71.3% |
| 2014 Q3 | 326 Million USD | 13.59% |
| 2014 Q2 | 287 Million USD | 5.9% |
| 2014 Q1 | 271 Million USD | 201.11% |
| 2014 FY | 1.18 Billion USD | 27.56% |
| 2014 Q4 | 301 Million USD | -7.67% |
| 2013 Q2 | 276 Million USD | 2.22% |
| 2013 Q1 | 270 Million USD | 0.0% |
| 2013 Q4 | 90 Million USD | -69.18% |
| 2013 FY | 929 Million USD | 0.0% |
| 2013 Q3 | 292 Million USD | 5.8% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Phreesia, Inc. | -136.88 Million USD | 1184.122% |
| Accuray Incorporated | -15.54 Million USD | 9646.478% |
| Align Technology, Inc. | 445.05 Million USD | -233.443% |
| Elevance Health Inc. | 5.98 Billion USD | 75.213% |
| AxoGen, Inc. | -21.71 Million USD | 6933.671% |
| Boston Scientific Corporation | 1.59 Billion USD | 6.842% |
| CVS Health Corporation | 8.34 Billion USD | 82.215% |
| Cardinal Health, Inc. | 852 Million USD | -74.178% |
| Centene Corporation | 2.7 Billion USD | 45.078% |
| DaVita Inc. | 691.53 Million USD | -114.595% |
| HCA Healthcare, Inc. | 5.24 Billion USD | 71.69% |
| Hologic, Inc. | 789.5 Million USD | -87.967% |
| Humana Inc. | 2.48 Billion USD | 40.378% |
| IDEXX Laboratories, Inc. | 845.04 Million USD | -75.613% |
| Laboratory Corporation of America Holdings | 418 Million USD | -255.024% |
| Masimo Corporation | 81.5 Million USD | -1720.859% |
| McKesson Corporation | 3 Billion USD | 50.566% |
| Patterson Companies, Inc. | 185.93 Million USD | -698.146% |
| Quest Diagnostics Incorporated | 854 Million USD | -73.77% |
| ResMed Inc. | 1.02 Billion USD | -45.355% |
| Henry Schein, Inc. | 416 Million USD | -256.731% |
| Teladoc Health, Inc. | -220.36 Million USD | 773.419% |
| Universal Health Services, Inc. | 717.79 Million USD | -106.744% |
| Veeva Systems Inc. | 525.7 Million USD | -182.288% |
| Baxter International Inc. | 2.65 Billion USD | 44.127% |
| Intuitive Surgical, Inc. | 1.79 Billion USD | 17.464% |
| Danaher Corporation | 4.2 Billion USD | 64.667% |
| Stryker Corporation | 3.16 Billion USD | 53.112% |
| Medtronic plc | 3.67 Billion USD | 59.63% |